DMRA Act for D2C Healthcare Brands India — What You Cannot Claim | ICG

DMRA Act — Drugs and Magic Remedies for D2C Healthcare Brands

Slug: `/insights/dmra-act-d2c-healthcare-brands-india` Primary KW: dmra act d2c healthcare india Meta title: DMRA Act for D2C Healthcare Brands India — What You Cannot Claim | ICG Meta desc: Drugs and Magic Remedies Act for D2C brands. What disease claims are prohibited, how DMRA interacts with FSSAI + Schedule J, compliant D2C content strategy. ICG. H1: The Drugs and Magic Remedies Act — the forgotten compliance framework that D2C health brands violate most. Author: ICG Editorial Schema: Article + FAQPage Priority: P1 Word count: ~2,000

Key sections:

Section 1: What the DMRA Act is The Drugs and Magic Remedies (Objectionable Advertisements) Act 1954 prohibits advertisements of drugs that make claims to cure or prevent diseases listed in a Schedule to the Act, claims for aphrodisiac properties, and claims for effects on body dimensions/weight beyond what is supportable.

Section 2: The DMRA Schedule conditions (summarised) The Schedule lists: specific diseases (Bright's Disease of the kidneys, cancer, blindness, cataract, deafness, diabetes, fits/epilepsy, hypertension, leucoderma, mental diseases, sexual dysfunction, various organ conditions). Advertisements claiming a drug cures, prevents, or treats these conditions are prohibited.

Section 3: DMRA + Schedule J + FSSAI — the triple framework for D2C brands D2C health supplement brands face three overlapping frameworks: DMRA (magic remedy / disease cure claims prohibition), Schedule J (drug advertising for listed conditions), FSSAI (health function claims require scientific substantiation). ICG maps each claim against all three frameworks before approving D2C client content.

Section 4: The most common DMRA violations in D2C healthcare marketing "Our product cures diabetes" (DMRA + Schedule J). "Restore your vision naturally" (DMRA — blindness/vision conditions). "Lose 10kg guaranteed" (DMRA — body dimension claims). "Treat your hypertension without medication" (DMRA + Schedule J). The common pattern: enthusiastic D2C copywriting crossing into prohibited disease-cure claim territory.

Section 5: Compliant D2C content strategy Health function claims (within FSSAI substantiation standards): "Supports healthy blood sugar levels." General wellness claims: "Promotes overall metabolic wellness." Ingredient benefit claims: "Contains chromium, which contributes to normal macronutrient metabolism." These are compliant alternatives to the prohibited disease-cure framing.

5 FAQs: DMRA vs Schedule J (which is more restrictive), penalty for DMRA violations, how ICG reviews D2C content for DMRA compliance, DMRA and ayurveda brands, DMRA and fitness/weight loss brands.